Guest guest Posted June 20, 2009 Report Share Posted June 20, 2009 " Emerging evidence suggests that, in conjunction with achieving a hematologic response and a cytogenetic response, achieving a molecular response to therapy may correlate with improved progression-free survival in patients with Ph+ CML. Intitative reverse-transcriptase polymerase chain reaction (Q-RT-PCR) is " The best way to assess molecular response in patients with Ph+ CML.2 Q-RT-PCR enables extremely low levels of Bcr-Abl RNA transcripts to be monitored over time.Timely access to consistent and easily interpretable Q-RT-PCR results is important for: a.. Assessing whether a patient with Ph+ CML has achieved or is trending toward a desired response to therapy2 b.. Helping to ensure that a patient’s treatment is optimized over time2 A group of international experts in Ph+ CML is currently working to establish a uniform standard for performing Q-RT-PCR and reporting and interpreting the results.2 These experts recommend that Q-RT-PCR be performed at least every 3 months to assess response to therapy.2 Look for more information on standardized PCR testing offered through CML Alliance™. ************************************ If you are interested in natural foods, you may be interested in reading this at the Real Food Channel. http://www.therealfoodchannel.com/ FYI, Lottie Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.